These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12189723)

  • 21. Forced degradation of therapeutic proteins.
    Hawe A; Wiggenhorn M; van de Weert M; Garbe JH; Mahler HC; Jiskoot W
    J Pharm Sci; 2012 Mar; 101(3):895-913. PubMed ID: 22083792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid-phase aggregation of proteins under pharmaceutically relevant conditions.
    Costantino HR; Langer R; Klibanov AM
    J Pharm Sci; 1994 Dec; 83(12):1662-9. PubMed ID: 7891292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The challenge of drying method selection for protein pharmaceuticals: product quality implications.
    Abdul-Fattah AM; Kalonia DS; Pikal MJ
    J Pharm Sci; 2007 Aug; 96(8):1886-916. PubMed ID: 17252608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of low levels of amorphous material (<5%) on the blending characteristics of a direct compression formulation.
    Mackin L; Sartnurak S; Thomas I; Moore S
    Int J Pharm; 2002 Jan; 231(2):213-26. PubMed ID: 11755273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of ultraviolet, visible, and infrared light imaging in protein-based biopharmaceutical formulation characterization and development studies.
    Klijn ME; Hubbuch J
    Eur J Pharm Biopharm; 2021 Aug; 165():319-336. PubMed ID: 34052429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biopharmaceutical formulation.
    Lee JC
    Curr Opin Biotechnol; 2000 Feb; 11(1):81-4. PubMed ID: 10679348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preformulation Characterization, Stabilization, and Formulation Design for the Acrylodan-Labeled Glucose-Binding Protein SM4-AC.
    Sahni N; Chaudhuri R; Hickey JM; Manikwar P; D'Souza A; Metters A; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2017 May; 106(5):1197-1210. PubMed ID: 28088457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technical decision making with higher order structure data: impact of a formulation change on the higher order structure and stability of a mAb.
    Gruia F; Du J; Santacroce PV; Remmele RL; Bee JS
    J Pharm Sci; 2015 Apr; 104(4):1539-42. PubMed ID: 25270279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of validated stability-indicating assay methods--critical review.
    Bakshi M; Singh S
    J Pharm Biomed Anal; 2002 Jun; 28(6):1011-40. PubMed ID: 12049968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stabilization of pharmaceuticals to oxidative degradation.
    Waterman KC; Adami RC; Alsante KM; Hong J; Landis MS; Lombardo F; Roberts CJ
    Pharm Dev Technol; 2002 Jan; 7(1):1-32. PubMed ID: 11852692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability study of W/O/W viscosified multiple emulsions.
    Ozer O; Muguet V; Roy E; Grossiord JL; Seiller M
    Drug Dev Ind Pharm; 2000 Nov; 26(11):1185-9. PubMed ID: 11068692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raman spectroscopy in pharmaceutical product design.
    Paudel A; Raijada D; Rantanen J
    Adv Drug Deliv Rev; 2015 Jul; 89():3-20. PubMed ID: 25868453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meeting the challenges in freeze-drying of pharmaceuticals and biologicals.
    Friess W; Winter G
    Eur J Pharm Biopharm; 2013 Oct; 85(2):161. PubMed ID: 23820293
    [No Abstract]   [Full Text] [Related]  

  • 34. Stabilization of therapeutic proteins by chemical and physical methods.
    Izutsu K
    Methods Mol Biol; 2005; 308():287-92. PubMed ID: 16082042
    [No Abstract]   [Full Text] [Related]  

  • 35. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?
    Almarsson O; Zaworotko MJ
    Chem Commun (Camb); 2004 Sep; (17):1889-96. PubMed ID: 15340589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced protein formulations.
    Wang W
    Protein Sci; 2015 Jul; 24(7):1031-9. PubMed ID: 25858529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Form finds function.
    Allen KN
    Nat Chem Biol; 2007 Aug; 3(8):452-3. PubMed ID: 17637773
    [No Abstract]   [Full Text] [Related]  

  • 38. Laser irradiation to produce amorphous pharmaceuticals.
    Titapiwatanakun V; Tankul J; Basit AW; Gaisford S
    Int J Pharm; 2016 Nov; 514(1):282-289. PubMed ID: 27863673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of the SeDeM diagram expert system for the formulation of Captopril SR matrix tablets by direct compression.
    Saurí J; Millán D; Suñé-Negre JM; Pérez-Lozano P; Sarrate R; Fàbregas A; Carrillo C; Miñarro M; Ticó JR; García-Montoya E
    Int J Pharm; 2014 Jan; 461(1-2):38-45. PubMed ID: 24284019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review.
    Stärtzel P
    J Pharm Sci; 2018 Apr; 107(4):960-967. PubMed ID: 29183741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.